← All Cs Diagnostics CORP filings

Cs Diagnostics CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
CSDX
Cs Diagnostics CORP
10-Q: CS Diagnostics Reports Q3 2025 Net Income Growth Amid Revenue Decline
CS Diagnostics Corp. achieved increased net income for the nine months ended September 30, 2025, driven by significant cost reductions, despite an 11% decrease in revenue.
OTC.Pink
CSDX
Cs Diagnostics CORP
10-Q: CSDX Reports Q2 Net Income Surge Amid Revenue Dip
CS Diagnostics Corp. reported a significant increase in net income for Q2 2025, driven by substantial cost reductions, despite a notable decline in revenue.